Holly Fernandez Lynch, a bioethicist and lawyer, studies drug development and what happens when the needs of patients and pharma companies don't align.

Holly Fernandez Lynch, a bioethicist and lawyer, studies drug development and what happens when the needs of patients and pharma companies don't align.

Griffith is an innovator in the study of health equity, and will teach in the School of Nursing and the Perelman School of Medicine.

Widespread adoption of digital health tools has the potential to improve health and health care for individuals and their communities, but realizing this potential requires anticipating and addressing...

Earlier this year, the International Association of Bioethics (IAB) hosted the biennial World Congress of Bioethics (WCB) in Doha, Qatar. Understandably, controversy surrounded the decision to hold th...

Trump often invokes the Right to Try Act. Who wouldn't want to let people who are dying and desperate try something that might help? But the appealing name belies the law's critical shortcomings.

Device allowing the user to control a computer cursor using their thoughts has been adjusted in a bid to prevent glitches with the first implant. Device allowing the user to control a computer cursor ...

There is growing interest in using embedded research methods, particularly pragmatic clinical trials, to address well-known evidentiary shortcomings afflicting ...

In this narrative medicine essay, a medical ethicist discusses the complexity of juggling the interests of members in online forums dedicated to rare

Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise.

Though not a new technology, new advancements have progressed this field significantly.

This week on "The Readout LOUD" podcast: What happens when an approved drug doesn't work? Why don't patients want gene therapy? And is MASH still a big deal?

In this Viewpoint, the Supreme Court case FDA v AHM is used to illustrate the tension the FDA faces between science and politics, and state authority over abort

The FDA has a choice to make about nutrition labels. It should not defer to food industry.

2023 APA/PDC Prize for Excellence and Innovation in Philosophy Programs: Philosophy Learning and Teaching Organization (PLATO) (Affiliated with the University of Washington)

These findings suggest that wealth inequality in the US is associated with significant inequities in survival. Wealth redistribution policies may substantially reduce those inequities and increase pop...